IDSF Anti-Doping Code
Art. 1: Fundamental Principles
i. Doping contravenes the fundamental principles
of DanceSport and medical ethics.
ii. Doping is prohibited.
iii. Recommending, proposing, authorizing, condoning
or facilitating the use of any substance method covered by the definition of
doping or trafficking herein is also forbidden.
iv. Anti-doping is one of the objects
included under Article 2 (c) and (d) of the IDSF Statutes.
v. Members of the IDSF are obliged to enforce this
Code within their own jurisdictions, as part of the terms of their membership
in IDSF.
vi. This Anti-Doping Code is an integral part
of the IDSF Statutes.
Art. 2: Definitions
i. [Definitions of Terms]
1. “Doping” means:
a) the use of a substance or method which is
potentially harmful to an athletes’ health and capable of enhancing his or her
performance, or either of them, or
b) the presence in an athlete’s body of a
Prohibited Substance or evidence of the use thereof, or evidence of the use of
a Prohibited Method of enhancing athletic performance.
2. “Blood Doping” means the administration of
blood, red blood cells or any other blood products to an athlete, which may or
may not be preceded by withdrawal of blood from an athlete who trains in a
blood-depleted state.
3. “Intentional Doping” means Doping in
circumstances where it is established, or may reasonably be presumed, that
anyone knowingly acted or alternatively knowingly failed, refused or neglected
to act with respect to any act or condition involving Doping.
4. “Masking Agent” means any substance or
procedure used for the purpose of or having the effect of altering or
suppressing the integrity of urine or other samples of body tissue or fluid
used in Doping controls.
5. “Participant” means any athlete, coach,
trainer, official, medical or para-medical personnel working with or in
connection with or treating athletes participating in or preparing for sports
competitions of IDSF-granted competitions and all competitions organized under
the authority, whether direct or delegated, of the IDSF or an IDSF member.
6. “Pharmaceutical, chemical and physical
manipulation” means the use of any substances and methods, including masking
agents which alter, attempt to alter or may reasonably be expected to alter the
integrity and validity of samples of urine or any other bodily fluid or tissue
used in doping controls, including, without limiting the generality of this
definition, catheterisation, urine substitution and tampering or either of
them, inhibition of renal excretion, such as by probenicid and Related
Substances, and alterations of testosterone and epitestosterone measurements,
such as epitestosterone application or bromantan administration.
7. “Prohibited Method” means any method so
defined in this Code.
8. “Prohibited Substance” means any substance so
defined in this Code.
9. “Related Substance” means any substance having
a pharmacological action and chemical structure or either of them similar to a
Prohibited Substance or any other substance referred to in this Code, including
but not limited to metabolites of a Prohibited Substance.
10. “Trafficking” means and shall be deemed to
occur when a person, without having expressly received prior authorization from
a body of competent jurisdiction,
a) manufactures, extracts, transforms,
prepares, stores, expedites, transports, imports, exports, transits, offers
subject to payment or free of charge, distributes, sells, exchanges, undertakes
the brokerage of, obtains in any form, prescribes, commercializes, makes over,
accepts, possesses, holds, buys or acquires Prohibited Substances in any
manner;
b) takes any measures to assist or achieve the
ends described in the last subparagraph hereof, including financing the same in
any way or serves as an intermediary for their financing, provokes or is
implicated in any way in the consumption or use of such substances, or
establishes means of procuring or consuming such substances;
c) is a party to Prohibited Methods.
11. “Use” means the application, ingestion,
injection or consumption by any means whatsoever of any Prohibited Substance,
or the use of any Prohibited Method, and, without limiting the generality of
that definition, includes counselling the use of, permitting the use of or
condoning the use of any prohibited substance or prohibited method.
12. “Member” means a IDSF member organization.
13. “Anti-Doping Representative” is an official of
the IDSF who is a member of the IDSF Presidium and who is appointed to that office
from time to time by the IDSF Presidium.
ii. [List of Prohibited Substances
and Prohibited Methods]
The International
Olympic Committee’s list or lists of Prohibited Substances and Prohibited
Methods published by the IOC from time to time, is hereby incorporated as an an
integral part of this Code. This list shall be constantly reviewed by the
Anti-Doping Representative, who may propose additions or amendments to it. Such
addition or amendment must be approved by the General Meeting, and shall come into
force three (3) months from the date of such approval. Additions or amendments
must be codified in Appendix A of this Anti-Doping Code below V. Additional
Regulations.
Art. 3: Scope
i. [Application]
1. This Code applies to all Participants.
2. Each Member must inform its registered member
dancers, trainers and functionaries about this Anti-Doping Code, its
Participants by handing them out a copy of this Code. Any Member that nominates
a Participant to any IDSF-granted DanceSport competition is deemed to have
recognized this Anti-Doping Code and to undertake to nominate to IDSF-granted
DanceSport competitions only Participants who have agreed to comply with all of
the duties set out in and flowing from this Anti-Doping Code and who have
signed the corresponding forms of consent (Appendix B).
3. Participants must, before they take part in a
IDSF-granted DanceSport competition, agree to comply with this Anti-Doping Code
by the forms of consent codified in Appendix B of this Anti-Doping Code. Signed
forms can either be sent by the Participants to the Member who is nominating
the Participant or to the organizer of the DanceSport competition; the latest
possibility being to sign the forms at checking in for the Dance
Sport competition. In any case, the forms must then be forwarded to the
Anti-Doping Representative.
4. At every IDSF-granted competition, a copy of
this Anti-Doping Code and of the Competition Rules must be held ready for
consultation.
5. All athletes are subject to doping controls
(urine analyses, blood tests and other authorized techniques for detecting
Prohibited Substances or Methods).
6. Notwithstanding the obligations of other
participants to comply with the provisions of this Code, it is the personal
responsibility of any athlete subject to the provisions of this Code to ensure
that he/she does not use or allow the use of any prohibited substance or any
prohibited method.
7. No athlete shall be allowed to compete in
his/her national championships, nor shall a member nominate an athlete to an
IDSF-granted competition, unless and until such athlete agrees to subject
him/herself to out-of-competition testing by both the Member and the IDSF.
8. Every Member shall inform the IDSF Anti-Doping
Representative of any positive result(s) obtained in the course of doping
controls carried out by that Member.
ii. [Responsibility for Doping Control]
1. At all international IDSF-granted DanceSport
competitions according to Rule 5 IDSF Competition Rules, the IDSF may, by
decision of the Anti-Doping Representative, transfer and assign its
responsibility for doping controls to the Member in whose jurisdiction the
competition takes place, or to the promoter of the competition, provided always
that if in the opinion of the Anti-Doping Representative, the Member or the promoter
may not discharge IDSF’s responsibilities for doping control in a satisfactory
manner, the Anti-Doping Representative may make other arrangements which in her
or its discretion are deemed to be satisfactory.
2. It is a condition of membership of the IDSF
that a Member includes within its constitution or statutes or bylaws or
competition rules:
a) a provision obliging that Member to conduct
out-of-competition doping controls, a report of which must be submitted to the
IDSF annually; and
b) a provision allowing the IDSF to conduct
doping controls at that Member’s National Championships or any similar meeting;
and
c) a provision allowing the IDSF to conduct
out-of-competition tests on that Member’s athletes.
d) It is the duty of any Member or officer of a
Member to assist the IDSF and, if appropriate or deemed appropriate by the
Anti-Doping Representative, other Members in the carrying out of such testing.
Any Member whose representative is found to be or to have been preventing,
delaying, impending, hindering or otherwise obstructing the carrying out of
such tests shall be liable to sanctions under the Statutes of the IDSF.
3. Out-of-competition testing of athletes
recorded on the IDSF Ranking List is implemented by WADA. Out-of-competition
testing of other athletes is implemented by Members.
4. In order to more fully and perfectly implement
this Code and its policies, the following applies regarding the recognition of
results from doping controls:
a) Every Member shall inform the IDSF
Anti-Doping Representative of any positive result(s) obtained in the course of
doping controls carried out by that member. These findings shall be considered
by the Anti-Doping Representative who shall, in her/his absolute discretion, on
behalf of all members of the IDSF, recognize any positive result(s) obtained.
These positive results of doping controls carried out by that member will then
be final and binding upon all members, who shall take all reasonably necessary
action to render such decision effective.
b) Where doping control has been carried out by
the IDSF, every member shall recognize the results of such doping controls and
shall take all necessary action to render such decision effective.
c) The Anti-Doping Representative may, on
behalf of all members of the IDSF, recognize the results of doping control
carried out by a sporting body other that the IDSF, or by a member of that
sporting body under rules and procedures different from those of the IDSF, if
he/she is satisfied that the testing was properly carried out and the rules of
the body conducting these tests afford sufficient protection to athletes.
d) Where it is proposed to recognize the
results of doping controls carried out by a sporting body other than the IDSF,
or by a member of that sporting body under rules and procedures different from
those of the IDSF, an athlete likely to be affected shall be given notice in
writing. Should he/she wish to make representations in writing, she or he shall
deliver them to the Anti-Doping Representative within a month after the date of
the notification of the athlete.
e) If the Anti-Doping Representative decides to
recognize the result of doping controls carried out by a sporting body other
than the IDSF, then the athlete shall be deemed to have breached the relevant
IDSF Rule and will be subject to the same sanctions and procedures according to
this Code as an athlete who has done so. All members shall take all necessary
action to ensure that this decision is effective.
Art. 4:
Implementation of Doping Controls
i. [Group of Athletes to be Tested] Doping
controls must be carried out
1. in Pair
Competitions, on six athletes, three of each sex: one member of the winning
pair and five further athletes all to be chosen by the drawing of lots;
2. in Team
Competitions, on six athletes, three of each sex: one member of the winning
team and five further athletes all to be chosen by the drawing of lots.
3. those
athletes whom the IDSF has actual reason to suspect of having contravened the
Anti-Doping Code.
ii. [Obligation to Tolerate Controls and
Furnish Information] Athletes must tolerate the carrying out of doping
controls and, insofar as is necessary, must actively participate, in particular
by means of declaring such medications as they have taken in the three days
prior to the carrying out of the doping control. These declared medications
shall be noted in the protocol of the doping control.
iii. [Nomination of a Doping Control Team]
1. The
organizer of the competition has to appoint a Doping Control Team (DCT) which
carries out doping controls on site.
2. A DCT
comprises at least two persons (the Head of the team and one or more helpers).
The sex of the athletes to be tested is to be taken into consideration when
choosing the DCT. At least one member of the DCT must be the same sex as the
athletes. The Head of the DCT must be a
physician.
iv. [Carrying Out the Doping Controls on Site]
The DCT shall travel to the competition without prior announcement and shall
there make themselves known to the organizer of the event, or the responsible
functionary. The latter then leads the DCT without delay to the rooms which
have been set aside for the doping controls and, if necessary, orders any
necessary changes to be made in order to guarantee that the doping control
tests can be carried out without complaint and in keeping with the respective
rules.
v. [Drawing Lots to Determine Athletes to be
Tested] If required according to Art. 4, para. 1, the Head of the DCT shall
draw lots to determine the athletes to be tested.
vi. [Notification of the Athletes]
1. Immediately
after the end of the competition or following the announcement of the final
result, those athletes who have been chosen (by lots) to undergo doping
controls are provably requested to make their way immediately to the doping
control room.
2. The athlete
is entitled to present himself/herself for the doping control with a person of
their choice (official, trainer, physician, masseur, etc.).
3. Moreover,
the athlete shall be informed of the possible consequences which shall take
effect should he/she not present himself/herself for testing.
4. As a matter
of principle the doping controls should be carried out with as little delay as
possible.
vii. [Procedure for Urine Controls]
1. In addition
to the athlete and the person accompanying him/her, only the following persons
should be present in the control room:
a) A
Representative of the organizer,
b) The
Doping Control Team.
2. Upon
arrival in the doping control room the athlete shall identify himself/herself
beyond doubt (licence, passport, ID card, etc. ).
3. The time of
arrival in the doping control room and personal details shall be entered into
the relevant documents by the DCT.
4. The athlete
himself/herself chooses the urine sample container (beaker). At least 75
millilitres of urine is to be passed into the container under the supervision
of a same-sex member of the DCT. Subsequently, the athlete chooses two
containers bearing a special code each containing two small bottles marked
(engraved) with an identical code number and the letters “A” or “B”. The
athlete himself/herself fills the collected urine into the two small bottles
(bottle “A” is filled two-thirds full; bottle “B” is filled one-third full).
Then the bottles are closed. It is appropriate to check that the bottles are
sealed properly. Then the bottles are duly stored in the containers. A special
seal is applied to the container.
5. The time of
urine sampling and the code numbers are noted in the protocol. Likewise, any
medications taken in the previous 72 hours (according to statements made by the
athlete) are also noted down in the protocol.
6. After the
athlete has made a final check of the data and the Versapak, he/she signs the
protocol and thus confirms that the doping control has been carried out
properly. Furthermore, the protocol is also signed by the Head of the DCT, the
person accompanying the athlete (if present) as well as the Anti-Doping
Representative (if present).
7. The athlete
receives a copy of the protocol.
8. The
protocols as well as the containers are packed, sealed and immediately conveyed
to the organizer of the competition by the DCT after the entire doping control
procedure has been completed. The organizer provides the further transportation
of the urine samples to the respective laboratory.
9. In the
event of the athlete being unable to pass sufficient urine after one or more
attempts, the available amount shall be kept safe in a Versapak bottle chosen
by the athlete himself/herself. Upon further passing of urine, the athlete
opens the bottle himself/herself and mixes the “old” urine with the “new”
urine. The amount of urine now present is divided between the two bottles
following as described above. The procedure then continues as previously
described.
viii.[Procedure for Blood
Controls]
1. Blood samples shall only be taken by medically
qualified personnel. Any official conducting Anti-Doping blood sampling shall
provide the athlete with evidence of medical qualification before blood samples
are taken.
2. No samples shall be taken unless an athlete
has had the blood sampling procedures explained to him or her and has signed
the form of consent to blood testing. If an athlete refuses to sign the form of
consent, a sample shall not be taken from him or her, provided always that such
a failure, other than in the circumstances set out below, will be deemed to be
an unauthorized refusal to submit to doping control.
3. The equipment necessary to conduct blood
sampling shall consist of the following items in sufficient quantity for each
test. Items a) to f) inclusive shall be of a quality suitable for blood
sampling for medical purposes and items a) to f) inclusive shall be disposable
and must be sterile if required by competent medical opinion:
a) Venous
canulae
b) Vacuum
tubes
c) Plastic
syringe-like holders for the vacuum sample tubes
d) Shipping
containers
e) Sterile
disinfectant serviettes
f)
Tourniquet
Items a) to d) inclusive, which are specific to an individual test, shall
be contained within a module (Blood Sampling Module).
4. The athlete shall choose a Blood Sampling
Module from a selection of at least two modules. The athlete shall select a
blood sampling module and sampling shall begin. The official conducting blood sampling
shall apply a tourniquet to the athlete’s arm. No attempt shall be made to take
blood from any other area of the athlete’s body. The head of the DCT shall
clean the skin with the supplied sterile disinfectant serviette and shall take
the blood sample from a superficial vein, preferably in the anti-cubital
region. The Head of the DCT shall attempt to do this as painlessly as possible.
Sufficient blood to fill four of the blood sample tubes to be found in the
Blood Sampling Module shall be withdrawn from an athlete during blood sampling.
5. An athlete shall be entitled to refuse to
provide a blood sample if:
a) the person intending to conduct blood
sampling is unable to provide evidence of an officially recognized professional
medical qualification;
b) the items a) and d) above under No. 3, to be
found in the blood sampling module, are not contained within clean, sealed
packaging or if such packaging is not intact;
c) an official proposes or attempts to withdraw
more than 25 millilitres of blood from the athlete.
6. The blood shall be withdrawn from the athlete
into the four vacuum tubes. These tubes will be put directly into the
transportation containers for the A & B Samples and these containers shall
be immediately sealed. Each sample tube shall be marked with a code number.
This code number should be written by the relevant official on the athlete’s
Doping Control Form. The athlete should ensure that the code on the sample
tubes corresponds to that entered by the official on the form.
7. The tested athlete, the accompanying person
(if present), the Anti-Doping Representative (if present) and the head of the
DCT must all sign the Doping Control Form, confirming that the above procedures
were carried out, provided always that if an athlete or any other person thinks
that the procedures were not carried out satisfactorily, she or he may declare
so on the Doping Control Form and state his or her reasons for dissatisfaction.
In the absence of any such declaration, the athlete shall be deemed to have
waived any alleged procedural breach.
8. The athlete shall also provide details on the
Doping Control Form of any medication recently taken by him or her and of
whether he or she has received a blood transfusion during the preceding six
months.
9. The
protocols as well as the containers are packed, sealed and immediately conveyed
to the organizer by the DCT. The organizer provides the further transportation
to the respective laboratory.
ix. [Storage and Despatch of Samples]
1. All persons who have physical custody of such
samples are obliged at all times to preserve and protect them and to provide
evidence of uninterrupted supervision and control of the same by authorized
personnel, in order to prevent tampering and in order to ensure that the
Anti-Doping policy of the IDSF may not be called into question or fall into
disrepute, and the Presidium is authorized to take all measures it deems
necessary in its absolute discretion against persons and Members who fail to
comply with this duty.
2. Before containers containing any urine or
blood are packed, it should be confirmed that all samples taken are present and
that the number is in accordance with the list of code numbers. All samples
should, if possible, be stored in a refrigerator or freezer.
3. The main “A” and reserve “B” samples should be
placed in a sealed, protective suitable outer container and should be
despatched to the laboratory as soon as possible after the doping control has
been carried out.
4. If at all possible, the outer container should
not be opened during transit to the laboratory. The IDSF will provide
identification labels, if required, for customs purposes. The opening of the
outer container will not, of itself, invalidate the doping control.
5. Samples provided by athletes for the purpose
of doping controls immediately become the property of the IDSF.
x. [Procedure Following Refusal to Submit to
Doping Control] If an athlete refuses to provide a urine or blood sample,
the possible consequences shall be presented to him/her. The refusal to allow a
doping control to be carried out is subject to punishment pursuant to Art. 5,
para. 7. If the athlete continues to refuse, this fact shall be recorded in the
protocol. This note shall be signed by the IDSF Anti-Doping Representative (if
present) and the Head of the DCT. The protocol shall immediately be passed on
to the IDSF Anti-Doping Representative.
xi. [Analysis of the Samples] The analysis
of the urine and blood samples may only be carried out by IOC-accredited laboratories.
The analyses are to be carried out as soon as possible after the samples have
reached the laboratory. The analyses are to be carried out using recognized
methods. The laboratory shall make the results of the analyses available in
writing.
xii. [Announcing the Results of the Analysis to
the Athlete]
1. The laboratory informs the organizer of the
results of the analysis in writing and the organizer undertakes to pass on the
results:
a) to the athlete, in the event of a negative
result;
b) to the athlete, in the event of a positive
result, with the request that he/she comment on the matter or provide
information on the desired further procedure (analysis of the “B” sample), to
the Anti-Doping Representative and to the Managing Committee of the Presidium
of the IDSF.
2. If the athlete desires that the “B” sample be
analysed, the organizer arranges the analysis. The athlete involved shall have
the right to be present while the analysis is carried out, or that a person
designated by him/her be present. The athlete shall carry the resulting costs
(in the event of a positive result) himself/herself.
3. The athlete
shall be granted the possibility of a “hearing”. The result of the “B” sample
shall be seen as final. Further analyses shall not be permitted.
xiii. [Costs] The IDSF carries the costs of
the sampling and testing of the samples taken. In the event of sanctions being
imposed (Art. 6 para. 5 No. 1), the athlete shall carry the costs of the
sampling and testing.
Art. 5: Sanctions
i. [Principles] It is an athlete’s duty to
ensure that no substance prohibited under this Code enters his body tissues or
fluids. Bans must be imposed in relation to the individual responsibility of
the athlete.
ii. [Rules of Evidence]
1. A positive blood or urine sample is prima
facie evidence of a athlete’s being responsible for a doping offence.
2. Evidence obtained from metabolic profiles
and/or isotopic ratio measurements may be used to draw definitive conclusions
regarding the use of anabolic androgenic steroids.
3. The success or failure of the use of a
prohibited substance or prohibited method is immaterial. It is sufficient that
the prohibited substance or prohibited method was used or attempted for the
offence of doping to be considered as having been committed and consummated.
iii. [Sanctions] In a case of doping,
1. the penalties for a first offence are as
follows:
a) If the prohibited substance used is
ephedrine, phenylpropanolamine, pseudoephedrine, caffeine, strychnine or
related substances:
aa) A written warning;
bb) A ban on participation in one or several
sports competitions in any capacity
whatsoever;
cc) A fine of up to CHF 20,000.00;
dd) Suspension from any competition for a period
of one to six months.
b) If the prohibited substance used is one
other than those referred to in paragraph a) above:
aa) A ban on participation in one or several
sports competitions in any capacity whatsoever;
bb) A fine of up to CHF 20,000.00;
cc) Suspension from any competition for a minimum
period of two years, provided always that in the case of specific, exceptional
circumstances to be evaluated in the first instance by the competent body,
there may be a provision for a possible modification of the two-year sanction.
2. In case of
a) Intentional Doping;
b) The use of a Masking Agent;
c) Manoeuvres or manipulation that may prevent
or distort any test contemplated in this Code;
d) Complicity or other forms of involvement in
an act of doping by members of a medical, pharmaceutical or related profession,
the sanctions
are as follows:
aa) If the prohibited substance used is
ephedrine, phenylpropanolamine, pseudoephedrine, caffeine or strychnine and
related substances:
aaa) A ban on participation in one or several sports competitions in any capacity whatsoever;
bbb) A fine of up to CHF 20,000.00;
ccc) Suspension from any competition for a period of two to eight years.
bb) If the prohibited substance used is one other
than those referred to in paragraph 1. above or if it is a repeat offence (a
repeat offence being constituted by a further case of doping perpetrated within
a period of ten years after the preceding sanction, whatever form it took and
whatever the reason for it, became final):
aaa) A life ban on participation in any sports event in any capacity whatsoever;
bbb) A fine of up to CHF 200,000.00;
ccc) Suspension (between four years and life) from all sports competition.
iv. [Suspension] The athlete shall be
suspended from any further competition from the time the IDSF Anti-Doping
Representative reports a positive blood or urine sample (“A” sample) to any
other member of the Managing Committee/Sports Court (Art. 6 II).
v. [Disqualification] Any case of doping
during a competition automatically leads to invalidation of the result obtained
(with all its consequences, including forfeit of any medals and prizes),
irrespective of any other sanction that may be applied, subject to the
provisions of paragraph III of this article. In the event of a dancer from a
Formation Team being disqualified, this disqualification extends to the entire
Formation Team.
vi. [Effect] The penalty for an offence
tted by a competitor and detected on the occasion of an out-of-competition test
shall be the same, mutatis mutandis, and shall take effect from the date the
positive result was recorded.
vii. [Refusal to Provide Samples] The
refusal to submit to doping control or to provide a blood or urine sample is a
frustration of evidence and a violation of the athlete’s cooperation duties. An
athlete shall only be entitled to refuse to provide a blood or urine sample in
circumstances where the mandatory procedures and safeguards set out in the IDSF
Anti-Doping Code and its other Anti-Doping regulations are not observed.
1. In case of
refusal to provide a sample the penalties for a first offence are as
follows:
a) A warning;
b) A ban on participation in one or several
sports competitions in any capacity whatsoever;
c) A fine of up to CHF 20.000,00;
d) Suspension from any competition for a period
of one to six months.
2. In case of refusal to provide a sample the
penalties for a second offence are as follows:
a) A ban on participation in one or several
sports competitions in any capacity whatsoever;
b) A fine of up to CHF 20,000.00;
c) Suspension from any competition for a period
of two to eight years.
3. In case of refusal to provide a sample the
penalties for a repeated offence are as follows:
a) A life ban on participation in any sports
event in any capacity whatsoever;
b) A fine of up to CHF 200,000.00;
c) Suspension (between four years and life)
from all sports competition.
viii. [Trafficking in Prohibited Substances] The
penalties for trafficking in prohibited substances other than in the normal
course of a recognized profession or trade are as follows:
1. For trafficking in Prohibited Substances the
penalty will be suspension for life from participation in any sports
organization, body, activity or event in any capacity whatsoever. In addition,
the offence(s) may be reported to the competent administrative and judicial
authorities by any natural or legal person. Any attempt to traffic shall be
penalized in the same manner as the act of trafficking itself.
2. Ignorance of the nature or composition of the
Prohibited Substances or the nature or effects of the Prohibited Methods in
question does not constitute attenuating circumstances or grounds for exemption
from punishment for trafficking or attempted trafficking.
ix. [Concurrent Penalties and Conditions] The
penalties set out in this Code may be applied concurrently insofar as they are
compatible and may be accompanied by measures prescribing regular or
unannounced tests of the athlete concerned over a specified period of time.
x. [Sanctions imposed by Members] An
athlete may only be sanctioned once for a Doping offence. Members must refrain
from imposing sanctions against an athlete if IDSF is taking up the case
against her or him according to this Code. The regulations for the recognition
of doping controls (Art. 3 para. 2 No. 4) apply also to the recognition of
sanctions respectively.
xi. [Medical Exemptions] An athlete may
request the Anti-Doping Representative to grant prior exemption allowing
him/her to take a substance normally prohibited under the IDSF Rules. Such an
exemption will only be granted in cases of clear and compelling clinical need.
Art. 6: Procedure in the Event of a Positive Doping Sample
i. [Suspension] In the event of an
athlete’s “A” sample testing positive, the Managing Committee of the IDSF
Presidium shall suspend the athlete if this seems necessary in the interests of
fair competition..
ii. [Invoking the Sports Court]
1. In the
event of a positive “A” sample, the Anti-Doping Representative shall call upon
the Managing Committee. The Managing Committee takes on the role of a Sports
Court of the IDSF.
2. The
Managing Committee decides on whether to introduce sanctions pursuant to Art. 5
of this Code, as well as on when to lift the suspension.
iii. [Procedure]
1. The
Managing Committee meets in camera.
2. The case is
heard. With the agreement of the involved persons and in the event of summary
proceedings, the decision can be made without a hearing.
3. The persons
involved shall be given the opportunity to state their case orally or in
writing. They may take counsel.
4. The
Managing Committee shall determine the time and place for the hearing. The
persons involved shall be informed by registered mail of the date of the
hearing at least two weeks prior to it.
5. In the
event of the persons involved not appearing after proper invitation, the
Managing Committee may base its decision on the records without a hearing.
6. The Chair
of the Managing Committee may, within his/her jurisdiction, allow written,
well-founded urgent decisions to be taken, insofar as this is deemed necessary
in order to uphold the Federation Rules, sporting discipline or the rights of
the athlete. A complaint may be lodged against urgent proceedings within the
period of one week. The Managing Committee decides on the complaint.
7. The
Managing Committee shall decide by majority vote. Less significant proceedings,
in particular such proceedings in which the fault is negligible, may be
dismissed on the grounds of triviality.
8. All
decisions made by the Managing Committee shall be justified in writing and
signed by all its members.
iv. [Reasons for Exclusion]
1. A
particular member of the Managing Committee shall be excluded from taking part
in a proceedings if
a) the
member himself/herself or an athlete from his/her national federation is
involved in the case;
b) someone
involved in the case
aa) is the fiancé/fiancée of a member of the
Managing Committee, or
bb)
is or was the husband/wife (i.e., even if the marriage no longer exists
according to the respective national law), or
cc)
is or was related in the direct line or by marriage, in the collateral line
twice removed or by marriage once removed.
2. Members of
the Managing Committee may declare themselves biased or may be declined by
another member on the grounds of suspicion of bias. In the latter case, a
challenging petition is to be justified in writing and to be attached to the
challenging petition without delay subsequent to its being made known. The
Chair of the Managing Committee decides on the justification.
3. In the
event of a member of the Managing Committee being excluded pursuant to Art. 6
para. 4, no. 1 or no. 2, the equivalent number of members shall be nominated
from the Presidium.
v. [Costs]
1. The
Managing Committee decides on the costs of the case.
2. In the
event of sanctions being imposed, the athlete shall carry the costs of the
case. Otherwise the IDSF shall carry the costs.
3. Costs
eligible for cost assessment are:
a)
Expenditures for witnesses and evidence,
b)
Necessary expenses of the persons involved (travel costs, accommodation,
meals), including the panel of judges.
Expenses
incurred through drawing on or authorizing third parties are not eligible for
cost assessment.
vi. [Right of Appeal]
1. There is no
right of appeal in the law courts against decisions taken by the Sports Court.
2. An appeal
may be lodged with the Court of
Arbitration for Sport, Lausanne, against decisions taken by the Sports
Court.
Art. 7: Taking Effect
This Anti-Doping Code has been approved by
the 2001 IDSF General Meeting. It will be effective from January 1, 2002.
Appendix
A: Prohibited Classes of Substances and Prohibited Methods
[SUBSTITUTES
APPENDIX A OF THE OMAC 1999
OLYMPIC
MOVEMENT ANTI-DOPING CODE
APPENDIX
A, as at 1st September 2001]
I. PROHIBITED CLASSES OF SUBSTANCES
A. Stimulants
Prohibited
substances in class (A) include the following examples:
amineptine,
amiphenazole, amphetamines, bromantan, caffeine*,
carphedon,
cocaine, ephedrines**, fencamfamin, formoterol***, mesocarb, pentetrazol,
pipradrol,
salbutamol***, salmeterol***, terbutaline***,
...
and related substances.
*
For caffeine the definition of a positive is a concentration in urine greater
than
12
micrograms per millilitre.
** For cathine, the definition of a positive is a
concentration in urine greater than 5
micrograms
per millilitre. For ephedrine and methylephedrine,
the definition of a positive is a
concentration
in urine greater than 10 micrograms per millilitre. For phenylpropanolamine and
pseudoephedrine,
the definition of a positive is a concentration in urine greater than
25
micrograms per millilitre.
***
Permitted by inhaler only to prevent and/or treat asthma and exercise-induced
asthma.
Written notification of asthma and/or exercise-induced
asthma by a respiratory or team
physician
is necessary to the relevant medical authority.
NOTE: All imidazole preparations are acceptable for
topical use. Vasoconstrictors may
be
administered with local anaesthetic agents. Topical preparations (e.g. nasal,
ophthalmological,
rectal)
of adrenaline and phenylephrine are permitted.
B. Narcotics
Prohibited
substances in class (B) include the following examples:
buprenorphine,
dextromoramide, diamorphine (heroin), methadone,
morphine,
pentazocine, pethidine,
...
and related substances.
NOTE:
codeine, dextromethorphan, dextropropoxyphene, dihydrocodeine,
diphenoxylate,
ethylmorphine, pholcodine, propoxyphene and tramadol are permitted.•2
C. Anabolic agents
Prohibited
substances in class (C) include the following examples:
1.
Anabolic androgenic steroids
a.
clostebol,
fluoxymesterone, metandienone, metenolone, nandrolone,
19-norandrostenediol,
19-norandrostenedione, oxandrolone, stanozolol,
...
and related substances.
b.
androstenediol,
androstenedione, dehydroepiandrosterone (DHEA),
dihydrotestosterone,
testosterone*,
...
and related substances.
Evidence
obtained from metabolic profiles and/or isotopic ratio measurements may be
used
to draw definitive conclusions.
*
The presence of a testosterone (T) to epitestostrone (E) ratio greater than six
(6) to
one
(1) in the urine of a competitor constitutes an offence unless there is
evidence that this ratio
is
due to a physiological or pathological condition, e.g. low epitestosterone
excretion, androgen
producing
tumour, enzyme deficiencies.
In
the case of T/E greater than 6, it is mandatory that the relevant medical
authority
conducts
an investigation before the sample is declared positive. A full report will be
written and
will
include a review of previous tests, subsequent tests and any results of
endocrine
investigations.
In the event that previous tests are not available, the athlete should be
tested
unannounced
at least once per month for three months. The results of these investigations
should
be included in the report. Failure to co-operate in the investigations will
result in
declaring
the sample positive.
2.
Beta-2 agonists
bambuterol,
clenbuterol, fenoterol, formoterol, reproterol, salbutamol*,
salmeterol*,
terbutaline*,
...
and related substances.
*Authorized
by inhalation as described in Article (I.A.).
For
salbutamol the definition of a positive under the anabolic agent category is a
concentration
in
urine greater than 1000 nanograms per millilitre.•3
D. Diuretics
Prohibited
substances in class (D) include the following examples:
acetazolamide,
bumetanide, chlortalidone, etacrynic acid, furosemide,
hydrochlorothiazide,
mannitol*, mersalyl, spironolactone, triamterene,
...
and related substances.
*
Prohibited by intravenous injection.
E. Peptide hormones, mimetics and analogues
Prohibited
substances in class (E) include the following examples and their analogues
and
mimetics:
1.
Chorionic Gonadotrophin (hCG) prohibited in males only;
2.
Pituitary and synthetic gonadotrophins (LH) prohibited in males only;
3.
Corticotrophins (ACTH, tetracosactide);
4.
Growth hormone (hGH);
5.
Insulin-like Growth Factor (IGF-1);
and
all the respective releasing factors and their analogues;
6.
Erythropoietin (EPO);
7.
Insulin;
permitted
only to treat athletes with certified insulin-dependent diabetes. Written
certification
of insulin-dependent diabetes must be obtained from an endocrinologist or team
physician.
The presence of an abnormal concentration of an
endogenous hormone in class (E) or
its
diagnostic marker(s) in the urine of a competitor constitutes an offence unless
it has been
proven
to be due to a physiological or pathological condition.
II. PROHIBITED METHODS
The
following procedures are prohibited:
1.
Blood doping: means the administration of blood, red blood cells/and or related
blood products to an athlete, which may be preceded by withdrawal of blood from
the athlete, who continues to train in such a blood-depleted state.
2.
Administering artificial oxygen carriers or plasma expanders;
3.
Pharmacological, chemical and physical manipulation.•4
III. CLASSES OF SUBSTANCES PROHIBITED IN CERTAIN
CIRCUMSTANCES
A. Alcohol
Where
the rules of a responsible authority so provide, tests will be conducted for
ethanol.
B. Cannabinoids
Where
the rules of a responsible authority so provide, tests will be conducted for
cannabinoids
(e.g. marijuana, hashish). At the Olympic Games, tests will be conducted for
cannabinoids.
A concentration in urine of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic
acid
(carboxy-THC)
greater than 15 nanograms per millilitre constitutes doping.
C. Local anaesthetics
Injectable
local anaesthetics are permitted under the following conditions:
a.
bupivacaine, lidocaine, mepivacaine, procaine, and related substances, can be
used but
not
cocaine. Vasoconstrictor agents may be used in conjunction with local
anaesthetics;
b.
only local or intra-articular injections may be administered;
c.
only when medically justified.
Where
the rules of a responsible authority so provide, notification of administration
may be
necessary.
D. Glucocorticosteroids
The
systemic use of glucocorticosteroids is prohibited when administered orally,
rectally,
or
by intravenous or intramuscular injection.
When
medically necessary, local and intra-articular injections of
glucocorticosteroids are permitted. Where the rules of a responsible medical
authority so provide, notification of administration may be necessary.
E. Beta-blockers
Prohibited
substances in class (E) include the following examples:
acebutolol,
alprenolol, atenolol, labetalol, metoprolol, nadolol, oxprenolol,
propranolol,
sotalol, and related substances.
Where
the rules of a responsible authority so provide, tests will be conducted for
beta-blockers.
SUMMARY OF URINARY CONCENTRATIONS
ABOVE FOR WHICH IOC-ACCREDITED LABORATORIES•5
MUST
REPORT FINDINGS FOR SPECIFIC SUBSTANCES
caffeine
> 12 micrograms/millilitre
carboxy-THC
> 15 nanograms/millilitre
cathine
> 5 micrograms / milliltre
ephedrine
> 10 micrograms / milliltre
epitestosterone
> 200 nanograms / millilitre
methylephedrine
> 10 micrograms / millilitre
morphine
> 1 microgram / millilitre
19-norandrosterone
> 2 nanograms /millilitre in males
19-norandrosterone
> 5 nanograms/millilitre in females
phenylpropanolamine
> 25 micrograms / millilitre
pseudoephedrine
> 25 micrograms / millilitre
salbutamol
(as
stimulant) > 100 nanograms/millilitre
(as
anabolic agent) >1000 nanograms/millilitre
T/E
ratio > 6
IV. OUT-OF-COMPETITION TESTING
Unless
specifically requested by the responsible authority, out-of-competition testing
is
directed
solely at prohibited substances in class I.C (Anabolic Agents), I.D
(Diuretics), I.E
(Peptide
Hormones, Mimetics and Analogues), and II. (Prohibited Methods).
LIST OF EXAMPLES OF PROHIBITED SUBSTANCES AND
PROHIBITED METHODS
CAUTION: This is not an exhaustive list of prohibited
substances. Many substances that do not
appear
on this list are considered prohibited under the term "and related
substances".
Athletes
must ensure that any medicine, supplement, over-the-counter preparation or any
other
substance
they use does not contain any Prohibited Substance.
STIMULANTS:
amineptine,
amfepramone, amiphenazole, amphetamine, bambuterol,
bromantan,
bupropion; caffeine, carphedon, cathine, cocaine, cropropamide,
crotethamide,
ephedrine, etamivan, etilamphetamine, etilefrine,
fencamfamin,
fenetylline, fenfluramine, formoterol, heptaminol, mefenorex,
mephentermine,
mesocarb, methamphetamine, methoxyphenamine,
methylenedioxyamphetamine,
methylephedrine, methylphenidate,
nikethamide,
norfenfluramine, parahydroxyamphetamine, pemoline,
pentetrazol,
phendimetrazine, phentermine, phenylephrine,
phenylpropanolamine,
pholedrine, pipradrol, prolintane, propylhexedrine,
pseudoephedrine,
reproterol, salbutamol, salmeterol, selegiline, strychnine,
terbutaline,
NARCOTICS:
buprenorphine,
dextromoramide, diamorphine (heroin), hydrocodone,
methadone,
morphine, pentazocine, pethidine,
ANABOLIC
AGENTS :
androstenediol,
androstenedione, bambuterol, boldenone, clenbuterol,
clostebol,
danazol, dehydrochlormethyltestosterone,
dehydroepiandrosterone
(DHEA), dihydrotestosterone, drostanolone,
fenoterol,
fluoxymesterone, formebolone, formoterol, gestrinone,
mesterolone,
metandienone, metenolone, methandriol, methyltestosterone,
mibolerone,
nandrolone, 19-norandrostenediol, 19-norandrostenedione,
norethandrolone,
oxandrolone, oxymesterone, oxymetholone, reproterol,
salbutamol,
salmeterol, stanozolol, terbutaline, testosterone, trenbolone,
DIURETICS
acetazolamide,
bendroflumethiazide, bumetanide, canrenone, chlortalidone,
ethacrynic
acid, furosemide, hydrochlorothiazide, indapamide, mannitol
(by
intravenous injection), mersalyl, spironolactone,
triamterene,
MASKING
AGENTS
bromantan,
diuretics (see above), epitestosterone, probenecid,
PEPTIDE
HORMONES, MIMETICS AND ANALOGUES•7
ACTH,
erythropoietin (EPO), hCG*, hGH, insulin, LH*, clomiphene*,
cyclofenil*,
tamoxifen*,
*
prohibited in males only
BETA
BLOCKERS
acebutolol,
alprenolol, atenolol, betaxolol, bisoprolol, bunolol, carteolol,
celiprolol,
esmolol, labetalol, levobunolol, metipranolol, metoprolol, nadolol,
oxprenolol,
pindolol, propranolol, sotalol, timolol.
V. ADDITIONAL REGULATIONS
[Cf. Art. 2 II.]
Appendix B: Forms of Consent
1. I hereby agree
to the terms of the IDSF Anti-Doping Code and agree to submit to those terms. I
am aware that if I violate the Anti-Doping Code, I may be subject to severe
disciplinary sanctions according to this Code. A copy of the IDSF Anti-Doping
Code has been handed out to me.
(Signature;
for minors signature of a parent)
2. I submit to
the regulations of the International Court of Arbitration for Sports, Lausanne,
Switzerland.
(Signature;
for minors signature of a parent)
3. I understand
that by signing this form I am granting my consent to a urine or/and blood sample
being taken from me. I understand that the urine or/and blood sample is to be
taken so that it may be analysed to determine whether it discloses the presence
of any substances prohibited under the IDSF Anti-Doping Code, and that if the
analysis of the sample reveals the presence of any such substance, or
deviations from the normal range in the case of endogenous substances, I may be
subject to disciplinary sanctions under the rules of the IDSF Anti-Doping Code.
I also understand that the analysis
of my sample might reveal evidence of disease. In such an instance I grant
consent for the appropriate information to be sent to me via the IDSF or my
national DanceSport federation, provided such information shall remain
confidential to the laboratory and myself and shall be contained within an
envelope sealed by the laboratory and bearing only my sample code number.
(Signature;
for minors signature of a parent)
IDSF Competition Rules
Rule 9
Anti-Doping
Doping is forbidden, according to the terms of the
IDSF Anti-Doping Code.
IDSF Statutes
Article 19
Rules and Regulations
1. The IDSF has the following rules and
regulations:
a)
Financial Regulations
b)
Competition Rules
c)
Rules for Adjudicating
d)
Regulations for television, advertising and sponsorship
e)
Anti-Doping Code
2. The Anti-Doping Code is part of the
statutes.
3. The other rules and regulations are not part
of the statutes and may be amended by
postal ballot or by the General Meeting.
APPROVED BY
THE 2001 IDSF GENERAL MEETING
EFFECTIVE JANUARY 1, 2002.
BY ORDER OF
THE IDSF GENERAL MEETING
AND
THE IDSF PRESIDIUM